Loading...
*  Rare Cancer News & Clinical Trials » PubMed - Acinar Cell Carcinoma » Dynamic landscape of pancreatic carcinogenesis reveals...
... using a well-established mouse model of pancreatitis and of inflammation-accelerated KrasG12D-driven pancreatic ductal ... PubMed - Acinar Cell Carcinoma * Dynamic landscape of pancreatic carcinogenesis reveals early molecular networks of malignancy. ... Rare Cancer News & Clinical Trials » PubMed - Acinar Cell Carcinoma » Dynamic landscape of pancreatic carcinogenesis reveals ... CONCLUSIONS: These data define a transcriptional signature of early pancreatic carcinogenesis and a molecular network driving ...
http://www.rare-cancer.org/news/PubMed_-_Acinar_Cell_Carcinoma/2017/12/20/Dynamic_landscape_of_pancreatic_carcinogenesis_reveals_early_molecular_networks_of_malignancy.
*  The utility of a novel antibody in the pathological diagnosis of pancreatic acinar cell carcinoma | Journal of Clinical...
However, no positive staining was found in other pancreatic tumours including NETs, SPNs and ductal adenocarcinomas. The ... Aims Acinar cell carcinomas (ACCs) are rare tumours of the exocrine pancreas accounting for about 1-2% of all pancreatic ... The utility of a novel antibody in the pathological diagnosis of pancreatic acinar cell carcinoma ... The utility of a novel antibody in the pathological diagnosis of pancreatic acinar cell carcinoma ...
http://jcp.bmj.com/content/65/4/327
*  Acinar cell carcinoma | definition of acinar cell carcinoma by Medical dictionary
What is acinar cell carcinoma? Meaning of acinar cell carcinoma medical term. What does acinar cell carcinoma mean? ... Looking for online definition of acinar cell carcinoma in the Medical Dictionary? acinar cell carcinoma explanation free. ... Many of the major types of pancreatic neoplasms (ductal adenocarcinoma, pancreatic endocrine neoplasm, acinar cell carcinoma, ... acinar cell carcinoma. acinar cell carcinoma. A highly aggressive tumour that represents 1-2% of all pancreatic malignancies, ...
http://medical-dictionary.thefreedictionary.com/Acinar+cell+carcinoma
*  Rare Cancer News & Clinical Trials » PubMed - Acinar Cell Carcinoma » November 2017
In contrast to pancreatic ductal adenocarcinoma, no recurrent point mutations are detected. The tumor suppressors ID3, ARID1A, ... Liver Metastases in Pancreatic Acinar Cell Carcinoma Treated with Selective Internal Radiation Therapy with Y-90 Resin ... Genome-wide genetic and epigenetic analyses of pancreatic acinar cell carcinomas reveal aberrations in genome stability. ... Background: Pancreatic acinar cell carcinoma (PACC) is a rare tumor. Surgical resection is the treatment of choice when ...
http://www.rare-cancer.org/news/PubMed_-_Acinar_Cell_Carcinoma/2017/11/
*  Rare Cancer News & Clinical Trials » PubMed - Acinar Cell Carcinoma » Stress-Activated NRF2-MDM2 Cascade Controls Neoplastic...
... lesions rarely become fully malignant pancreatic ductal adenocarcinoma (PDAC). The molecular mechanisms through which ... Influence of Ground-Glass Opacity and... Pancreatic acinar cell carcinoma: A r... → ... PubMed - Acinar Cell Carcinoma * Stress-Activated NRF2-MDM2 Cascade Controls Neoplastic Progression in Pancreas.. ... Rare Cancer News & Clinical Trials » PubMed - Acinar Cell Carcinoma » Stress-Activated NRF2-MDM2 Cascade Controls Neoplastic ...
http://www.rare-cancer.org/news/PubMed_-_Acinar_Cell_Carcinoma/2017/12/22/Stress-Activated_NRF2-MDM2_Cascade_Controls_Neoplastic_Progression_in_Pancreas.
*  Rare Cancer News & Clinical Trials » Google - Acinar Cell Carcinoma
MYC in pancreatic cancer: novel mechanistic insights and their translation into therapeutic strategies. Nature.com. As multiple ... recent studies have described acinar cells undergoing acinar to ductal metaplasia as a common cell of origin of PDAC (and ... Google - Acinar Cell Carcinoma (5 unread) * This RSS feed URL is deprecated. ... A report in Nature Medicine describes the creation of a new autochthonous mouse model of clear cell renal cell carcinoma (ccRCC ...
http://news.rare-cancer.org/Google_-_Acinar_Cell_Carcinoma/
*  Successful salvage chemotherapy with FOLFIRINOX for recurrent mixed acinar cell carcinoma and ductal adenocarcinoma of the...
Ductal adenocarcinoma; FOLFIRINOX; Multimodal treatment; Pancreatic cancer; Pancreatoblastoma. ... Here, we report the case of a 15-year-old boy who presented with a mixed acinar cell carcinoma/ductal adenocarcinoma with ... Here, we report the case of a 15-year-old boy who presented with a mixed acinar cell carcinoma/ductal adenocarcinoma with ... Successful salvage chemotherapy with FOLFIRINOX for recurrent mixed acinar cell carcinoma and ductal adenocarcinoma of the ...
http://www.zora.uzh.ch/id/eprint/84478/
*  Abstract 1543: Clinical significance of ZNF185 intracellular localization in pancreatic ductal carcinoma | Cancer Research
Abstract 1543: Clinical significance of ZNF185 intracellular localization in pancreatic ductal carcinoma. Daisuke Furukawa, ... Clinical significance of ZNF185 intracellular localization in pancreatic ductal carcinoma. [abstract]. In: Proceedings of the ... Abstract 1543: Clinical significance of ZNF185 intracellular localization in pancreatic ductal carcinoma ... Abstract 1543: Clinical significance of ZNF185 intracellular localization in pancreatic ductal carcinoma ...
http://cancerres.aacrjournals.org/content/76/14_Supplement/1543
*  Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states. | Clinical Cancer Research
Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states.. N Suehara, K Mizumoto, T ... Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states.. N Suehara, K Mizumoto, T ... Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states.. N Suehara, K Mizumoto, T ... Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states. Message Subject (Your Name) ...
http://clincancerres.aacrjournals.org/content/3/6/993
*  Identification and validation of differential expressed apoptotic genes in microdissected pancreatic ductal carcinomas | Cancer...
Identification and validation of differential expressed apoptotic genes in microdissected pancreatic ductal carcinomas. ... Identification and validation of differential expressed apoptotic genes in microdissected pancreatic ductal carcinomas ... Identification and validation of differential expressed apoptotic genes in microdissected pancreatic ductal carcinomas ... Identification and validation of differential expressed apoptotic genes in microdissected pancreatic ductal carcinomas ...
http://cancerres.aacrjournals.org/content/67/9_Supplement/3581
*  pancreatic ductal carcinoma
Build: Fri Jul 27 09:23:34 EDT 2018 (commit: a5c8d99). National Center for Advancing Translational Sciences (NCATS), 6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-435-0888. ...
https://pharos.nih.gov/idg/diseases/DOID:3587
*  The Neurotrophin-Trk Receptor Axes Are Critical for the Growth and Progression of Human Prostatic Carcinoma and Pancreatic...
... have been implicated in the development and progression of human prostatic carcinoma and pancreatic ductal adenocarcinoma. We ... The human prostate carcinoma cell line PC-3, the human prostatic/bladder carcinoma TSU-Pr1, and the human ovarian carcinoma ... pancreatic, lung, and medullary thyroid carcinoma (5, 6, 7, 8, 9, 10) . Specifically, human prostatic carcinoma cells have been ... RT-PCR detection of trkA expression in PC-3 prostatic, CFPAC pancreatic, and SK-OV-3 ovarian carcinoma tumor cell lines but not ...
http://clincancerres.aacrjournals.org/content/8/6/1924
*  "Proteomic profiling of pancreatic ductal carcinoma cell lines treated with trichostatin-A" | IRIS...
"Proteomic profiling of pancreatic ductal carcinoma cell lines treated with trichostatin-A". ... "Proteomic profiling of pancreatic ductal carcinoma cell lines treated with trichostatin-A" ... A pancreatic adenocarcinoma cell line (Paca44) was treated with trichostatin-A (TSA), a potent inhibitor of histone ... A pancreatic adenocarcinoma cell line (Paca44) was treated with trichostatin-A (TSA), a potent inhibitor of histone ...
https://iris.univr.it/handle/11562/301231
*  Pancreatic Ductal Carcinoma: Slow Progress for a Hard-to-Treat Cancer - Let's Win! Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC), which is considered incurable, accounts for more than 90% of pancreatic cancer cases. ... Resource Library Pancreatic Cancer Connections Symptoms Stages Videos What Is Standard of Care? Glossary ... Resource Library Pancreatic Cancer Connections Symptoms Stages Videos What Is Standard of Care? Glossary ... Let's Win! Pancreatic Cancer is an online community for sharing information about innovative, science-based treatments for ...
https://letswinpc.org/newsfeed/2018/01/23/pancreatic-ductal-carcinoma-slow-progress-hard-treat-cancer/
*  July 2013 - Volume 37 - Issue 7 : The American Journal of Surgical Pathology
Pancreatic Intraglandular Metastasis Predicts Poorer Outcome in Postoperative Patients With Pancreatic Ductal Carcinoma. Oguro ... Most Nonparotid "Acinic Cell Carcinomas" Represent Mammary Analog Secretory Carcinomas. Bishop, Justin A.; Yonescu, Raluca; ... Signet Ring Cell Colorectal Carcinoma: A Distinct Subset of Mucin-poor Microsatellite-stable Signet Ring Cell Carcinoma ... Clear Cell Odontogenic Carcinomas Show EWSR1 Rearrangements: A Novel Finding and a Biological Link to Salivary Clear Cell ...
http://journals.lww.com/ajsp/toc/2013/07000
*  Napabucasin | STAT inhibitor | Read Reviews & Product Use Citations
Carcinoma Pancreatic Ductal. Boston Biomedical Inc. December 2016. Phase 3. NCT02826161 Terminated. Carcinoma Non-Small-Cell ...
https://www.selleckchem.com/products/napabucasin.html
*  A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo...
Pancreatic ductal adenocarcinoma (PDA). Pancreatic ductal carcinoma. PEGylated Recombinant Human Hyaluronidase (PEGPH20). Nab- ... Stage IV Pancreatic Ductal Adenocarcinoma Other: Biological: PEGylated Recombinant Human Hyaluronidase (PEGPH20) Drug: Placebo ... Stage IV pancreatic ductal adenocarcinoma (PDA) with histological or cytological confirmation of PDA. ... high Stage IV previously untreated pancreatic ductal adenocarcinoma (PDA). Participants will be randomized in a 2:1 ratio to ...
https://clinicaltrials.gov/ct2/show/NCT02715804
*  PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Subjects With Stage IV Untreated...
pancreatic ductal carcinoma(PDA). Pancreatic ductal carcinoma. PEGPH20. Gemcitabine. Nab-paclitaxel. Additional relevant MeSH ... Non metastatic pancreatic ductal adenocarcinoma. *Evidence of deep vein thrombosis (DVT) or pulmonary embolism (PE) or other ... Subjects must have newly diagnosed stage 4 untreated metastatic pancreatic ductal cancer diagnosed by a standard of Care CT ... Histologically confirmed Stage IV pancreatic ductal adenocarcinoma w/ documented disseminated neoplasm to liver and /or lung. ...
https://clinicaltrials.gov/ct2/show?term=pegph20&rank=3
*  A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma - Full...
Pancreatic Ductal. Carcinoma. Neoplasms, Glandular and Epithelial. Neoplasms by Histologic Type. Neoplasms. Carcinoma, Ductal. ... Carcinoma, Pancreatic Ductal Drug: Napabucasin Drug: Nab-paclitaxel Drug: Gemcitabine Phase 3 ... Neoplasms, Ductal, Lobular, and Medullary. Pancreatic Neoplasms. Digestive System Neoplasms. Neoplasms by Site. Endocrine Gland ... Must have histologically or cytologically confirmed advanced pancreatic ductal adenocarcinoma (PDAC) that is metastatic. The ...
https://clinicaltrials.gov/ct2/show/study/NCT02993731?term=CanStem111P&rank=1&show_locs=Y
*  Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors - Full Text View -...
Carcinoma, Pancreatic Ductal Esophageal Squamous Cell Carcinoma Drug: paclitaxel + carboplatin Drug: carboplatin + etoposide ... Carcinoma, Pancreatic Ductal. Triple Negative Breast Neoplasms. Neoplasms, Glandular and Epithelial. Neoplasms by Histologic ... small cell lung carcinoma (SCLC), and gastric/gastro-esophageal junction (GEJ) cancer, pancreatic ductal adenocarcinoma (PDAC) ... Small Cell Lung Carcinoma Carcinoma, Squamous Cell of Head and Neck Stomach Neoplasms Triple Negative Breast Neoplasms Ovarian ...
https://clinicaltrials.gov/ct2/show/NCT02658214
*  Search of: amatuximab - List Results - ClinicalTrials.gov
Carcinoma, Pancreatic Ductal. *Mesothelioma. *Ovarian Neoplasms. *Carcinoma, Non-Small-Cell Lung. *Drug: Amatuximab (MORab-009) ... A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer. *Pancreatic ... An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer. *Pancreatic Cancer ...
https://clinicaltrials.gov/ct2/results?cond=&term=amatuximab&cntry1=&state1=&recrs=
*  Identificação de fatores diabetogênicos associados ao adenocarcinoma de pâncreas
Pancreatic ductal carcinoma. S100 proteins. Resumo em inglês. Pancreatic ductal adenocarcinoma is closely related to diabetes ... Pancreatic adenocarcinoma patients who had diabetes mellitus had higher HOMA-IR (p < 0.05) and a trend to lower HOMA-beta ... Of these, 25 were five times more expressed in diabetic patients? pancreatic adenocarcinomas. Three genes were chosen for RT- ... Clinical and laboratorial data of 33 patients with pancreatic adenocarcinoma were evaluated, and tumor gene expression was ...
http://www.teses.usp.br/teses/disponiveis/5/5135/tde-30102006-152027/pt-br.php
*  Rare Cancer News & Clinical Trials » PubMed - Acinar Cell Carcinoma » Cell of origin affects tumour development and phenotype...
PubMed - Acinar Cell Carcinoma * Cell of origin affects tumour development and phenotype in pancreatic ductal adenocarcinoma.. ... Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive tumour thought to arise from ductal cells via pancreatic ... Cell of origin affects tumour development and phenotype in pancreatic ductal adenocarcinoma. ... CONCLUSION: These findings indicate that ductal cells are primed to form carcinoma in situ that become invasive PDAC in the ...
http://news.rare-cancer.org/PubMed_-_Acinar_Cell_Carcinoma/2018/01/26/Cell_of_origin_affects_tumour_development_and_phenotype_in_pancreatic_ductal_adenocarcinoma.
*  Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of INNO-206 in Advanced Pancreatic Cancer
... or unresectable pancreatic ductal carcinomas (PDA) who have failed prior chemotherapy with gemcitabine regim ... in Subjects With Advanced or Unresectable Pancreatic Ductal Carcinoma Whose Tumors Have Progressed Following Prior Treatment ... in Subjects With Advanced or Unresectable Pancreatic Ductal Carcinoma Whose Tumors Have Progressed Following Prior Treatment ... metastatic pancreatic ductal adenocarcinoma.. - Cancer progression after treatment with one gemcitabine and one. ...
http://www.knowcancer.com/cancer-trials/NCT01580397/